Briton Yates not suspended after failing drug test: UCI
LONDON (Reuters) - British rider Simon Yates, a strong contender to make Britain's Olympic cycling team, will not be provisionally suspended after failing a drugs test, the sport's governing body, the Union Cycliste Internationale (UCI), said on Friday.
Yates, one of the brightest prospects in British cycling, failed the test due to an "administrative error" over the use of an asthma inhaler, his team Orica-GreenEDGE said.
The UCI said in a statement that Yates had not been suspended because "such a substance does not entail imposition of a provisional suspension".
The Bury-born 23-year-old had returned an adverse analytical finding for Terbutaline, a common treatment for asthma, from a test conducted at the Paris-Nice stage race last month, Orica-GreenEDGE said in a statement.
"The substance was given in an ongoing treatment of Simon Yates' documented asthma problems," the Australian team said.
"However, in this case the team doctor made an administrative error by failing to apply for the TUE (therapeutic use exemption) required for the use of this treatment.
"This is solely based on a human error that the doctor in question has taken full responsibility for," they added.
"There has been no wrongdoing on Simon Yates' part. The team takes full responsibility for this mistake and wishes to underline their support for Simon during this process."
In its statement, the UCI said: "As per the UCI's anti-doping rules, such substance does not entail the imposition of a provisional suspension. Continued...